Fundraising Fox

Matthew Calistri

Investor

Associate at Bain Capital Venture · Managing Director at Bain Capital Life Sciences

Boston

Find your path to Matthew

466 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.

Alice PillarunlockedMatthew: together at Investment Technology Group, Inc. (2014)
×2Matthew: together at The University of Chicago Booth School of Business
Matthew: together at UBS Investment Bank
×6Matthew: together at Fordham University

About

Matthew Calistri is a Managing Director in the Portfolio Group of Bain Capital's Life Sciences business, which he joined in 2024. He previously spent four years at Cerevel Therapeutics, serving as VP of Investor Relations and VP of Corporate Strategy, and held investor relations roles at Sage and Biogen. Earlier in his career he worked in financial services at Gerson Lehrman Group, ITG, UBS, Bankers Trust, and E&Y, and he holds an MBA in finance from the University of Chicago Booth School of Business and a BS in accounting from Fordham University.

Invests in

Biotech

Experience

  1. Bain CapitalManaging Directorcurrent2024 — presentBoston, Massachusetts, United States
  2. Cerevel Therapeutics, LLCVice President - Investor Relations2020 — 2024Boston, Massachusetts, United States
  3. Cerevel Therapeutics, LLCVice President - Corporate Strategy and Investor Relations2021 — 2022Cambridge, Massachusetts, United States
  4. Sage TherapeuticsVice President - Investor Relations2019 — 2020Cambridge, USA
  5. BiogenVice President, Investor Relations2017 — 2019
  6. BiogenSenior Director - Investor Relations2015 — 2017Cambridge, MA
  7. BiogenSenior Director - Corporate Strategy2014 — 2015Cambridge, MA
  8. Investment Technology Group, Inc.Director - Boston Research Sales2011 — 2014
  9. Gerson Lehrman GroupManaging Director2001 — 2011
  10. UBS Investment BankInstitutional Sales1999 — 2001
  11. Ernst & YoungSenior Auditor1992 — 1995

Skills & more

Bloomberg5Microsoft PowerPointStrategy19Hedge Funds28Financial Analysis12Sales13Portfolio Management5Capital Markets9Sales Management8Investments24Marketing Strategy7Financial Modeling20
+10 moreEquitiesAlternative InvestmentsFinanceAccount ManagementCompetitive AnalysisAsset ManagementDue DiligenceValuationInvestment BankingBusiness Strategy

From Matthew's professional profile.

Colleagues at Bain Capital Venture

Ajay Agarwal
Partner at Bain Capital Ventures
Alena Harrison
Operating Partner at Bain Capital Double Impact Fund LP
Alexander Katz
Investor at Bain Capital Real Estate
Alexandra Assante
Vice President, Treasury at Bain Capital Venture
Alfred Bonfantini
Director at Bain Capital Credit
Alyson Goff
Associate at Bain Capital Life Sciences
Aman Jain
Investment Associate at Varanium NexGen
Amanda Conklin
Vice President at Bain Capital Double Impact Fund LP

Frequently asked questions

Who is Matthew Calistri?
Matthew Calistri is a Managing Director in the Portfolio Group of Bain Capital's Life Sciences business, which he joined in 2024. He previously spent four years at Cerevel Therapeutics, serving as VP of Investor Relations and VP of Corporate Strategy, and held investor relations roles at Sage and Biogen. Earlier in his career he worked in financial services at Gerson Lehrman Group, ITG, UBS, Bankers Trust, and E&Y, and he holds an MBA in finance from the University of Chicago Booth School of Business and a BS in accounting from Fordham University.
Where does Matthew Calistri work?
Matthew Calistri is Associate at Bain Capital Venture.
What does Matthew Calistri invest in?
Matthew Calistri invests in Biotech.
Where did Matthew Calistri go to school?
Matthew Calistri studied at The University of Chicago Booth School of Business (MBA, Finance); Fordham University (B.S., Accounting).

Same school

Also attended The University of Chicago Booth School of Business785

Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital

+ 779 more

Also attended Fordham University111

Joseph R. SavianoFounder and Managing Member at Dot CapitalMatthew StoneCOO at FJ LabsJack LutkewittePrincipal at Orkila CapitalErin WrightExecutive Assistant at Longitude CapitalKerrie CohenManaging Director, Global Head of Communications & Marketing at Warburg PincusMark SancrantPartner, M&A Advisory at eGateway Capital

+ 105 more

Shared employers

Also worked at Sage Therapeutics6

Jeffrey M. JonasPartner at Cure VenturesAlbert J. RobichaudPartner at Cure VenturesKiran ReddySenior Managing Director at Blackstone Life SciencesJamil BegPartner at 5AM VenturesAsha NayakInvestor at Johnson & Johnson Innovation – JJDCDario DollerCo-founder at Modulate Bio

Also worked at Investment Technology Group, Inc.14

Alice PillarInvestor at Moonfire VenturesMinder ChengManaging Member at Thirdstream PartnersRachel WanPartner at Camford CapitalDaniel AbramovAdvisor at Gibraltar VenturesNaveen RaoCraft Advisory Board at Craft VenturesJarrett LilienInvestor at Vestigo Ventures

+ 8 more

Also worked at Gerson Lehrman Group80

Juan Carlos SotoVenture Partner at Copper Sky CapitalShant SoodInvestor at Riverwood CapitalNatalie JohnstonInvestment Principal at 4BIO CapitalEric KwongDirector, Finance/Ops at FINTOP CapitalEvan AuyangGroup President at Animoca BrandsMinh DoChief Operating Officer at Animoca Brands

+ 74 more

Also worked at UBS Investment Bank1,011

Vlad YatsenkoCo-founder & CTO of RevolutJen WangDeal Operations Manager at Felicis VenturesMartin MignotInvestor at Index VenturesBirgitteInvestor at InvestinorSauvanne Saint-LégerInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone

+ 1,005 more